A roundup of autism papers and media mentions you may have missed.
The agency that oversees the drug approval process in Europe is moving to Amsterdam, gene editing gets its first human trial, and a tiny sensor detects even a few oxytocin molecules in blood.
An interview for diagnosing adults on the spectrum clears its first hurdle, a fragile X drug eases multiple features of the syndrome in a mouse model, and a brain bank chronicles the beautiful diversity of neurons.
Black parents are less likely than white parents to report concerns about autism features in their children, human brain organoids in rodent bodies raise ethical concerns, and science graduate programs in the United States have few American students.
Two new gadgets join the gene-editing toolbox, many children with autism get smarter with age, and a survey points to a research reset for Autism Speaks.
Two researchers balk at talk that Wi-Fi and autism are linked, changes in an autism risk gene are tied to obsessive-compulsive traits in three species, and scientists plan to conduct a census of all of the brain’s cell types.
A mouse model of autism reveals sex differences in brain function and behavior, incontinence and autism often co-occur, and a new literature search engine summarizes neuroscience hits into interactive visuals.
Taking prenatal multivitamins may reduce the risk of having a child who has autism with intellectual disability, another vaccine-autism link study is being retracted, and schizophrenia sometimes accompanies autism.
A cannabis gel may ease features of fragile X syndrome, omega fatty acids show promise for autism in two trials, and oxytocin reinforces social behaviors through the brain’s reward pathway.
A re-analysis of data yields an increased estimate for the genetic contribution to autism, how the environment might contribute to autism is hard to pin down, and students on the spectrum describe the benefits of using technology at school.
A gene called TRIO may be a hotbed for autism mutations, an international collaboration focuses on the whole brain and one behavior, and Autism Speaks cuts grant spending.
